IDEAYA Biosciences IDYA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$19.03M (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 44.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 10.78% to 8.54% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +655,274 | 9.9% |
| FMR | Mutual Fund | 2026/Q3 | +363,303 | 15.0% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +211,628 | 0.4% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +179,060 | 4.5% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +224,281 | 0.5% |
| AllianceBernstein | Mutual Fund | 2026/Q3 | +1,526,735 | 1.7% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +1,314,628 | 8.9% |
| Deerfield Management Company, L.P. | Hedge Fund | 2026/Q3 | +1,184,495 | 2.8% |
| Baker Bros. Advisors LP | Hedge Fund | 2026/Q3 | +1,063,515 | 5.2% |
| FMR | Mutual Fund | 2026/Q3 | +932,945 | 14.6% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +891,608 | 0.9% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +891,582 | 2.3% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +767,744 | 4.7% |
| Sio Capital Management, LLC | Hedge Fund | 2026/Q3 | +480,383 | 0.5% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +459,686 | 4.9% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 5 Oct 2026 | Yujiro Hata | Chairperson & CEO | Derivative Exercise and Sale | -26,338 | $38.26 | 690,695 |
| 6 Jul 2026 | Andres Briseno | Chief Accounting Officer | Derivative Exercise and Sale | -9,550 | $40.01 | 26,466 |
| 15 Jun 2026 | Wendy Yarno | Independent Director | Other Derivative Acquisition | +20,000 | $30.57 | 20,000 |
| 15 Jun 2026 | Jeffrey Stein | Independent Director | Other Derivative Acquisition | +20,000 | $30.57 | 20,000 |
| 15 Jun 2026 | Scott William Morrison | Independent Director | Other Derivative Acquisition | +20,000 | $30.57 | 20,000 |
| 15 Jun 2026 | Catherine Mackey | Independent Director | Other Derivative Acquisition | +20,000 | $30.57 | 20,000 |
| 15 Jun 2026 | Terry Rosen | Lead Independent Director | Other Derivative Acquisition | +20,000 | $30.57 | 20,000 |
| 15 Jun 2026 | Malcolm Hampton | Independent Director | Other Derivative Acquisition | +20,000 | $30.57 | 20,000 |
| 1 Mar 2026 | Jeffrey Stein | Independent Director | Open Market Acquisition | +50,000 | $32.96 | 61,007 |
| 29 Jan 2026 | Yujiro Hata | Chairperson & CEO | Other Derivative Acquisition | +600,000 | $32.19 | 600,000 |
| 29 Jan 2026 | Douglas Snyder | Chief Legal Officer | Other Derivative Acquisition | +130,000 | $32.19 | 130,000 |
| 29 Jan 2026 | Darrin Beaupre | Chief Medical Officer | Other Derivative Acquisition | +175,000 | $32.19 | 175,000 |
| 29 Jan 2026 | Andres Briseno | Chief Accounting Officer | Other Derivative Acquisition | +80,000 | $32.19 | 80,000 |
| 29 Jan 2026 | Michael White | President of Research & Development | Other Derivative Acquisition | +190,000 | $32.19 | 190,000 |
| 29 Jan 2026 | Stuart Dorman | Chief Commercial Officer | Other Derivative Acquisition | +155,000 | $32.19 | 155,000 |
| 29 Jan 2026 | Joshua Bleharski | Chief Financial Officer | Other Derivative Acquisition | +170,000 | $32.19 | 170,000 |
| 27 Nov 2025 | Douglas Snyder | Chief Legal Officer | Other Acquisition | +2,080 | $16.91 | 2,080 |
| 27 Nov 2025 | Andres Briseno | Chief Accounting Officer | Other Acquisition | +1,935 | $23.26 | 26,466 |
| 26 Jun 2025 | Joshua Bleharski | Chief Financial Officer | Initial Statement of Beneficial | +0 | – | 250,000 |
| 23 Jun 2025 | Wendy Yarno | Independent Director | Other Derivative Acquisition | +20,000 | $21.78 | 20,000 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 8,236,480 | 8.5% | 8.9 |
| 15 Oct 2026 | 9,079,434 | 9.4% | 12.0 |
| 30 Sep 2026 | 9,183,217 | 9.5% | 8.4 |
| 15 Sep 2026 | 9,931,622 | 10.3% | 17.3 |
| 31 Aug 2026 | 10,103,757 | 10.5% | 12.2 |
| 14 Aug 2026 | 10,398,078 | 10.8% | 16.5 |
No comments yet — be the first to weigh in on IDYA.
Sign in to join the discussion.